ABOUT MEDIQAI

Our Purpose. Our Approach. Our Direction.

Our Purpose

MediQAI is developing a patent-pending connected-health platform that brings together multimodal wearable sensing, a patient-specific Physiological Digital Twin, predictive intelligence and clinician-directed care.

Our Approach

The proposed system is designed to connect physiological measurements with symptoms, medication, behaviour, medical history and longitudinal clinical context. This may help identify meaningful changes that isolated readings or universal thresholds could overlook.

Our Direction

MediQAI is currently progressing through prototype development, engineering definition, quality and regulatory planning, and preparation for controlled validation with appropriate clinical, research and technology partners.

MediQAI connected-health innovation
CONNECTED BY DESIGN

One Coordinated Connected-Health Architecture

MediQAI’s proposed architecture combines complementary technology layers to support longitudinal, patient-specific monitoring and proportionate clinical review.

Multimodal Wearable

Captures physiological, movement, location, safety and patient-reported information over time.

Physiological Digital Twin

Connects measurements and events with the individual’s evolving baseline and clinical context.

Predictive Intelligence

Recognises meaningful combinations of change beyond isolated readings and universal thresholds.

Evidence-Led

Technical and clinical claims will be supported through appropriate testing, verification and controlled validation.

Patient-Specific

The proposed platform is designed around the individual’s changing baseline rather than relying solely on population-wide thresholds.

Partnership-Driven

MediQAI welcomes engagement with clinical, research, engineering, regulatory and healthcare-system partners.

OUR LONG-TERM AMBITION

From Passive Monitoring to Proactive Care

MediQAI’s long-term ambition is to transform fragmented health information into a connected, longitudinal picture that supports earlier recognition, informed clinical review and more personalised care.